跳至主要内容
临床试验/NCT06165445
NCT06165445已完成不适用

Optimized Multichannel tDCS Protocol vs Conventional and Sham tDCS for Clinical Use in Patients With Major Depressive Disorder

The National Brain Mapping Laboratory (NBML)1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Montgomery-Asberg Depression Rating Scale scores

研究概览

简要总结

In this project, the efficacy of different tDCS protocols in major depression will be investigated. The tDCS protocols have already been investigated in humans, and results showed that stimulation intensity has a different effect on tDCS long-term aftereffects based on the human motor cortex model. The project has three major goals: first, we want to see if the differential outcome of tDCS dosage, as present in healthy populations, can be translated to patients with major depression. Second, we want to compare the efficacy of a multi-channel novel protocol with conventional tDCS modules. Lastly, we are interested in the safety and tolerability of optimized multi-channel. The project output will be an optimized tDCS protocol for major depression treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

to secure investigator blinding, interventions were applied by independent investigators who were not involved in outcome measure ratings

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Meet DSM-5 criteria for a moderate-to-severe major depression, primarily by a DSM-5-based structured interview by a licensed psychiatrist, confirmed by score on Hamilton Rating Scale for Depression (HAMD)
  • being 18-60 years old
  • providing written informed consent
  • If female, negative urine pregnancy test
  • Treatment naïve or on a stable standard antidepressant regimen (including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MOAIs) or tricyclics (TCAs)) with no change in treatment 6-weeks prior to and during the tDCS intervention

排除标准

  • pregnancy
  • alcohol or substance dependence
  • history of seizure
  • history of neurological disorder
  • comorbid Schizophrenia Axis I disorder, bipolar disorder, substance abuse or dependence, dementia, personality disorder
  • history of head injury
  • currently receiving any form of Cognitive Behavioral Therapy, Dialectical Behavioral Therapy, or Acceptance and Commitment Therapy
  • Presence of ferromagnetic objects in the body that are contraindicated for brain stimulation of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments)

研究组 & 干预措施

conventional tDCS group

Active Comparator

The conventional tDCS group will receive 30 sessions of 20-minute stimulation at 2 mA intensities using standard electrodes (7 x 5 cm) over the target region

干预措施: transcranial direct current stimulation (tDCS) (Device)

multi-channel tDCS group

Active Comparator

The multi-channel tDCS group will receive 30 sessions of 20-minute stimulation at 2 mA intensities using 7 electrodes (11 mm) over the target region

干预措施: multichannel transcranial direct current stimulation (tDCS) (Device)

sham tDCS group

Placebo Comparator

The conventional tDCS group will receive 30 session of 20-minute placebo stimulation using standard electrodes (7 x 5 cm) over the target region

干预措施: transcranial direct current stimulation (tDCS) (Device)

结局指标

主要结局

Montgomery-Asberg Depression Rating Scale scores

时间窗: up to 3 months after the intervention

the score on the MADRS (Montgomery-Asberg Depression Rating Scale)

Hamilton Depression Rating Scale scores

时间窗: up to 3 months after the intervention

the score on the Hamilton Depression Rating Scale (HDRS). The HDRS is a multiple-item questionnaire designed for measuring adult depression and is administered by health care professionals. It is currently the most common depression measure used worldwide. Items on the HDRS are scored from 0 to 4 or 0 to 2 depending on the symptom assessed, with high scores indicating greater symptom pathology. scores typically ranging from 15 to 20 indicate a clinical level of depressive symptomatology

Beck Depression Inventory scores

时间窗: up to 3 months after the intervention

the score on the Beck Depression Inventory (BDI-II). The BDI is a self-reported twenty-one questions about how the subject has been feeling in the last week, and each question has four answers ranging in intensity. Scoring 19 or higher on the BDI-II is considered moderate depression

次要结局

  • Working memory task(up to 1 month after the intervention)
  • Attention task(up to 1 month after the intervention)
  • electroencephalogram (EEG) functional connectivity(up to 1 week after the intervention)
  • Emotion Recognition Task(up to 1 month after the intervention)
  • electroencephalogram (EEG) power(up to 1 week after the intervention)

研究者

发起方
The National Brain Mapping Laboratory (NBML)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammad Ali Salehinejad

Principal Investigator

RWTH Aachen University

研究点 (1)

Loading locations...

相似试验